Recommended Global Oncology & Cancer Webinars & Conferences
Europe & UK
Asia Pacific & Middle East
Cancer and Care 2022
Organizing committee of Cancer and Care 2022 invites all the participants from all over the world to attend “Annual Conference on Cancer Research” going to be held in April 18-19, 2022 Miami, USA. The primary topic of the conference is "Exploring Advancements in Cancer Care".
Cancer & Care 2022 is a global platform for keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects. The conference invites Pathologists, Oncologists, Radiologists, Academicians, Clinical Researchers, Students, Young researchers, Medical Devices Companies and business delegates across the globe to share views, exchange knowledge and establish research collaborations & networking.
Why to attend:
Cancer & Care 2022 is an international platform for presenting research about diagnosis, prevention and management and exchanging ideas about it and thus, contributes to the dissemination of knowledge in Cancer Care and Research for the benefit of both the academia and business.
The organizing committee of this Cancer & Care 2022 Conference is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Cancer & Care 2022, where you will be sure to have a meaningful experience with scholars from all around the world. All members of the Cancer & Care Conference and Organizing Committee look forward to meeting you in Miami, USA.
Cancer prevention is an accomplishment drags towards lower chance of getting cancer. In 2019, 1.8 million people were diagnosed with cancer in the United States. Not only the physical problems but also the emotional distress was caused by cancer, the expensive costs of care are also an obligation to patients, their families, and to the public. With the prevention cancer, the number of new cases of cancer can be reduced. Expectantly, this will moderate the load of cancer and cancer death number will decrease. The risk of cancer can be condensed through diet and other lifestyle change. Tobacco is precisely associated with cancer, so precluding tobacco can reduce the danger of lung cancer. Reducing the level of alcohol can reduce the danger of neck throat and oesophageal cancer. Persuading exposed skin by smearing sunscreen lotions in order to reduce the risk of skin cancer. Cancer can be Aspects handled by many treatments like chemotherapy, radiation therapy, hormonal therapy, target therapy, and palliative care.
- Hereditary Aspects
- Food Habitats
- Immunized Aspects
- Chronic Inflammation
Cancer vaccines generally either treats existing cancer or prevents development of a cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells, or pure antigens. Sometimes a patient’s own immune cells are removed and exposed to these substances in the lab to create the vaccines.
- Cancer Vaccines
- CAR T-Cell Therapy
- Oncolytic viral therapies
- Gene therapy
- Adoptive T-Cell transfer
- Therapeutic Cancer Vaccines
- HPV & Hepatitis B vaccine
- Personalised Cancer Vaccines
- Clinical Trails
Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumours or malignancies). It is a field of research that aims to discover cancer immunotherapies to treat and retard progression of the disease. Cancer immunotherapy also known as Immuno-oncology is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). The immune response, including the recognition of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumor marker-based diagnostic tests.
- Host-Tumour Relation
- Cancer Immunosurveillance and Immunoediting
- Clinical Cancer immunology
- Cancer Antigens & Vaccines
- Cellular Immunotherapy
- Antibody Therapy
- Cytokine Therapy
- Combination & Combinatorial Ablation and Immunotherapies
Many factors influence the development of cancer. Over the last 25 years, science has shown that diet, physical activity, and body weight, especially being overweight or obese are major risk factors for developing certain types of cancer. Around a third of the most common cancers could be prevented through lifestyle changes. The main behavioural and environmental risk factors for cancer mortality in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles. The body’s ability to resist cancer may be helped by following a healthy diet, staying physically active, and avoiding excess body fat. Cancer and cancer treatments can also affect your body's ability to tolerate certain foods and use nutrients.
- Lifestyle Factors
- Combined Impact
- Population Attributable Risks
- Investigation into Cancer and Nutrition (EPIC)
Unlike diagnostic efforts prompted by symptoms and medical signs, cancer screening involves efforts to detect cancer after it has formed, but before any noticeable symptoms appear. This may involve physical examination, blood or urine tests or medical imaging.
Cancer screening is not available for many types of cancers. Even when tests are available, they may not be recommended for everyone. Universal screening or mass screening involves screening everyone. Selective screening identifies people who are at higher risk, such as people with a family history. Several factors are considered to determine whether the benefits of screening outweigh the risks and the costs of screening.
- Screening mammography
- Prostate Cancer Screening
- Pancreatic Cancer Screening
- Oral Cancer Screening
- Lung Cancer Screening
- Colorectal Cancer Screening
- Cervical Cancer Screening
- Breast Cancer Screening
- Whole Body Imaging
- Innovation in Genetic Testing
Malignant growth depends on the area of disease cells happen specifically organ. There are more than 200 different types of cancer diagnosed. Among them, Lung cancer, breast cancer is the most common cancer diagnosed in 2015. Apart from this prostate cancer, colon cancers, bladder cancer, breast cancer are the most common type cancer. The rare types of cancers are which affect the bone known as Bone Cancer. Depending upon the location of cancer the causes, symptoms, and method of treatments vary. Carcinoma, Sarcoma, leukaemia, lymphoma, and melanoma are the types of cancer found in different organs.
- Head & Neck Oncology
- Urological Oncology
Cancer Genetics and Epigenetics:
Risk expectation and prediction and Cancer prevention, growth counteractive action is also promising and encouraging areas of Epigenetics. A high adequacy of demethylating agents were accounted for essentially in haematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumours. During the cell’s transformation to Cancerous cell, Epigenetic modifications are also more important like genetic mutation. Their manipulation brings a great promising approach for inventing, detecting and treatment of cancer.
- Clinical Applications
- Germ Line Changes
- Hereditary Cancer Syndrome
Cancer that spread to a different part of the body from where it started is called metastasis. For example, a breast cancer that spread to the liver is referred to as metastatic breast cancer. The most common sites where cancer spreads are the bone, liver, and lung. The clinical manifestation of metastasis in a vital organ is the ultimate phase of cancer progression and the main offender of cancer-related mortality.
- Organ-Specific Targets
- Diagnosis & Management
- Multimodal therapies
Pathology In Cancer:
Pathologists are among the most important members of a patient’s cancer care team. They work to diagnose and determine the stage of cancer, setting the course for what comes next in the treatment journey. Diagnosis and staging are just the beginning of a cancer pathologist’s work. He or she also studies the tumour’s molecular structure to determine whether it is likely to be sensitive to certain chemotherapy drugs, hormone treatments or other cancer therapies. Dr. Garcia says antibodies have become the tool of choice for this task, because they have the ability to find and latch on to key proteins. A marker on the antibody’s other end offers clues as to whether a specific therapy may help fight the cancer. Pathologists may also look to genomic tests to assess whether a targeted therapy, either one that is on the market or one being tested in clinical trials, may offer another option. Cancer pathology’s key role in diagnosing and treating a complex disease, it’s important to stay up to date on new technologies and breakthroughs that continue to shape the ever-evolving landscape of cancer care. Making good use of that expertise is not limited to determining a diagnosis or recommending treatment options.
- Anatomical Pathology
- Molecular pathology of cancer
- Pathology in cancer diagnostics
- Cancer Cytopathology
- Forensic Pathology
- Pediatric pathology
It is another integrated region including organic, measurable and computational sciences. Now a day’s bioinformatics modification is for the most part utilized for the special growth investigation. Ribosomal S6 protein kinase 4 (RSK4) is a fundamental novel tumour silencer that binds breast cancer cell development and commence senescence. Utilizing pair proclivity cleaning, we got protein buildings that correlate with RSK4 or RSK4m. Mass range examination was performed to differentiate the acquired protein edifices, and bioinformatics investigation was performed.
- Cancer Bioinformatics
- Translational Bioinformatics
- Bioinformatics Gene
- Bioinformatics Drug
- Biology Bioinformatics
The Cancer Biomarkers are the substance that acts as an indicator of the cancer site in the body. Usually the biomarker is a computable indicator of biological state in the body; it is a molecule which is unleashed by the tumour or in response to the presence of tumour. The biomarkers are used for the assessment of risk for cancer patients. The cancer biomarkers specifically related with genetic mutations or epigenetic alteration always gives the measurable way to find the tumour cells. The most advantageous ability of biomarker is that they can be used as a diagnostic tool, determines whether the tumour is localized or metastatic in nature. The cancer prognosis can also be determined by the biomarkers. In prognosis, the forcefulness of the recognized cancer and the response to the given treatment. Cancer recurrence is also being examined by the biomarkers. In Cancer Therapy and Treatments the biomarkers play an important role. Cancer science Meetings gives dynamic interactions about the contribution of biomarkers towards cancer therapy.
- Diagnosis and Risk assessment
- Prognosis and Treatment
- Biomarkers in cancer development research
- Biomarkers in drug
Radiation Therapy and its side effects:
It is one of the cancer treatment techniques. In Radiation therapy by the usage of ionizing radiation the cancer cells will be damaged. In this process of radiation therapy some normal cells also effects. Mostly, normal cells can recover from these effects and work properly. The main aim of radiation therapy is to kill cancer cells as much as possible by damaging their DNA. Meanwhile, in this process some surrounding healthy organs also effects. Radiation therapy does depend on various factors like type of cancer and sensitivity and some other. This radiation therapy can also be used as a part of adjuvant therapy.
- Distinguish the radio sensitivity of a particular tumour
- Damaging the DNA of cancerous cells
- 3-dimensional confirmation radiation therapy
- Radio surgery
- Intensity-modulated radiation therapy
Cells which are present in tumour and have the capabilities of self-renewing and ability to give rise to many cells are known as cancer stem cells. Cancer stem cell model also known as hierarchical model process. Cellular therapies are a part of complimentary treatment regimens.
- Stem cell mutation
- Cancer stem cell and immunology model
- Stochastic model
Past Conference Report
All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.
Abstracts will be provided with Digital Object Identifier by